Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987;109(12):783-7.

[Role of pulsatile liberation of gonadotropins in the development of amenorrhea]

[Article in German]
  • PMID: 3115000

[Role of pulsatile liberation of gonadotropins in the development of amenorrhea]

[Article in German]
M Hámori et al. Zentralbl Gynakol. 1987.

Abstract

The authors performed serial gonadotropin determinations of 25 patients with secondary amenorrhea. In addition repeatedly 17-beta-estradiol, prolactin, testosterone and progesterone determinations were carried out in every case, too. The cause of amenorrhea was hyperprolactinemia in 3 patients and elevated LH secretion (polycystic ovarian syndrome) in 5 other patients. In half of the remaining 18 cases the serial LH levels exhibited a decrease, as well as the physiological pulsation disappeared. Very low prepubertal estradiol secretion and negative gestagene and clomiphene tests were more likely at these patients. The medicinal treatment (Clostilbegyt, Pergonal, Choriogonin) was unsuccessful in more of half of the cases with restricted pulsatile pattern. According to the authors' the cessation of pulsatile LH activity results in the failure of ovarian function, in very low estradiol secretion and in lasting amenorrhea. The hormonal picture is similar to that observed during the prepubertal period (relatively high FSH level, low and tonic LH secretion). The insusceptibility of the adequate receptors in the hypothalamic-pituitary-ovarian system brings about often the failure of the clomiphene or gonadotropin treatment. Since the lack of endogenous gonadotropin-releasing hormone represents the basis of the disorder, the administration of luteinizing hormone-releasing hormone (LH-RH) in appropriate rhythm would be the solution for the patients.

PubMed Disclaimer

Publication types